News

QuidelOrtho and BÜHLMANN Laboratories AG announced the availability of the fCAL® turbo and fPELA® turbo assays on VITROS™ Systems, enabling rapid and non-invasive diagnosis of IBD and pancreatic insufficiency.

New QC-Scheme for GanglioCombi – Summary from PNS 2025 Poster Presentation We are pleased to inform you about recent developments presented at the Peripheral Nerve Society (PNS) Annual Meeting 2025 in Edinburgh, where we showcased our latest work on improving the quality control of the multiparametric GanglioCombi IVD test kits (BÜHLMANN GanglioCombi® MAG ELISA, in

BÜHLMANN Laboratories AG today announced the appointment of Eric Hrimech to the newly created position of global Chief Commercial Officer (CCO).

BÜHLMANN Laboratories AG announced the appointment of Christian Eberle as its new CEO.